DNA Earnings — Ginkgo Bioworks Holdings, Inc. Post-ER Performance | BigEarnings
DNA — Ginkgo Bioworks Holdings, Inc.
XNYS · Healthcare · Biotechnology
Price$9.37
Market Cap$612.1M
P/E—
52W Range$5.37 – $17.58
Next Earnings2026-08-06
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
